跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
VIMPAT 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
VIMPAT 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 24, 2025
Approval ID
dfc3a055fc872881
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
dfc3a055fc872881
Drug Cima Aemps Name
VIMPAT 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
08470008IP1
Holder Company Name
Ucb Pharma
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/ucb-pharma-sa
Authorization Date
2025-10-24
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 24, 2025
Approval ID
dfc3a055fc872881
Type
Standard
Back to CIMA-AEMPS Approvals
VIMPAT 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
